In 94% (292/310) of all CHORD-HRD patients, we found mono- or biallelic inactivation of at least one of the four HRD associated genes (BRCA1, BRCA2, PALB2, RAD51C; Fig. 4c). Here, BRCA2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.